208 related articles for article (PubMed ID: 9125579)
1. Characterization of the physiological requirements for the bactericidal effects of a monoclonal antibody to OspB of Borrelia burgdorferi by confocal microscopy.
Escudero R; Halluska ML; Backenson PB; Coleman JL; Benach JL
Infect Immun; 1997 May; 65(5):1908-15. PubMed ID: 9125579
[TBL] [Abstract][Full Text] [Related]
2. Functional heterogeneity in the antibodies produced to Borrelia burgdorferi.
Benach JL
Wien Klin Wochenschr; 1999 Dec; 111(22-23):985-9. PubMed ID: 10666815
[TBL] [Abstract][Full Text] [Related]
3. A monoclonal antibody to OspA inhibits association of Borrelia burgdorferi with human endothelial cells.
Comstock LE; Fikrig E; Shoberg RJ; Flavell RA; Thomas DD
Infect Immun; 1993 Feb; 61(2):423-31. PubMed ID: 7678585
[TBL] [Abstract][Full Text] [Related]
4. A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein.
Sadziene A; Jonsson M; Bergström S; Bright RK; Kennedy RC; Barbour AG
Infect Immun; 1994 May; 62(5):2037-45. PubMed ID: 7513309
[TBL] [Abstract][Full Text] [Related]
5. Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey.
Aydintug MK; Gu Y; Philipp MT
Infect Immun; 1994 Nov; 62(11):4929-37. PubMed ID: 7927774
[TBL] [Abstract][Full Text] [Related]
6. Access of antibody or trypsin to an integral outer membrane protein (P66) of Borrelia burgdorferi is hindered by Osp lipoproteins.
Bunikis J; Barbour AG
Infect Immun; 1999 Jun; 67(6):2874-83. PubMed ID: 10338494
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies with in vitro borreliacidal activities define the outer surface proteins A and B of Borrelia burgdorferi.
Moskophidis M; Luther B
Zentralbl Bakteriol; 1993 Jun; 279(2):201-13. PubMed ID: 8219491
[TBL] [Abstract][Full Text] [Related]
8. Molecular analysis of neutralizing epitopes on outer surface proteins A and B of Borrelia burgdorferi.
Ma J; Gingrich-Baker C; Franchi PM; Bulger P; Coughlin RT
Infect Immun; 1995 Jun; 63(6):2221-7. PubMed ID: 7539408
[TBL] [Abstract][Full Text] [Related]
9. A bactericidal monoclonal antibody elicits a change in its antigen, OspB of Borrelia burgdorferi, that can be detected by limited proteolysis.
Katona LI; Ayalew S; Coleman JL; Benach JL
J Immunol; 2000 Feb; 164(3):1425-31. PubMed ID: 10640758
[TBL] [Abstract][Full Text] [Related]
10. Crystallization and preliminary X-ray analysis of Borrelia burgdorferi outer surface protein A (OspA) complexed with a murine monoclonal antibody Fab fragment.
Li H; Lawson CL
J Struct Biol; 1995; 115(3):335-7. PubMed ID: 8573475
[TBL] [Abstract][Full Text] [Related]
11. Limited surface exposure of Borrelia burgdorferi outer surface lipoproteins.
Cox DL; Akins DR; Bourell KW; Lahdenne P; Norgard MV; Radolf JD
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7973-8. PubMed ID: 8755587
[TBL] [Abstract][Full Text] [Related]
12. Selection of an escape variant of Borrelia burgdorferi by use of bactericidal monoclonal antibodies to OspB.
Coleman JL; Rogers RC; Benach JL
Infect Immun; 1992 Aug; 60(8):3098-104. PubMed ID: 1639477
[TBL] [Abstract][Full Text] [Related]
13. Structural investigation of Borrelia burgdorferi OspB, a bactericidal Fab target.
Becker M; Bunikis J; Lade BD; Dunn JJ; Barbour AG; Lawson CL
J Biol Chem; 2005 Apr; 280(17):17363-70. PubMed ID: 15713683
[TBL] [Abstract][Full Text] [Related]
14. Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi.
Ma J; Bulger PA; Davis DR; Perilli-Palmer B; Bedore DA; Kensil CR; Young EM; Hung CH; Seals JR; Pavia CS
Vaccine; 1994 Aug; 12(10):925-32. PubMed ID: 7975834
[TBL] [Abstract][Full Text] [Related]
15. Presence of common antigenic epitope in outer surface protein (Osp) A and OspB of Japanese isolates identified as Borrelia garinii.
Masuzawa T; Kaneda K; Suzuki H; Wang J; Yamada K; Kawabata H; Johnson RC; Yanagihara Y
Microbiol Immunol; 1996; 40(6):455-8. PubMed ID: 8839432
[TBL] [Abstract][Full Text] [Related]
16. The hamster immune response to tick-transmitted Borrelia burgdorferi differs from the response to needle-inoculated, cultured organisms.
Roehrig JT; Piesman J; Hunt AR; Keen MG; Happ CM; Johnson BJ
J Immunol; 1992 Dec; 149(11):3648-53. PubMed ID: 1431134
[TBL] [Abstract][Full Text] [Related]
17. Characterization of canine humoral immune responses to outer surface protein subunit vaccines and to natural infection by Lyme disease spirochetes.
Ma J; Bulger PA; Dante S; Davis DR; Perilli-Palmer B; Coughlin RT
J Infect Dis; 1995 Apr; 171(4):909-15. PubMed ID: 7706819
[TBL] [Abstract][Full Text] [Related]
18. Structural identification of a key protective B-cell epitope in Lyme disease antigen OspA.
Ding W; Huang X; Yang X; Dunn JJ; Luft BJ; Koide S; Lawson CL
J Mol Biol; 2000 Oct; 302(5):1153-64. PubMed ID: 11183781
[TBL] [Abstract][Full Text] [Related]
19. Identification of a highly cross-reactive outer surface protein B epitope among diverse geographic isolates of Borrelia spp. causing Lyme disease.
Shoberg RJ; Jonsson M; Sadziene A; Bergström S; Thomas DD
J Clin Microbiol; 1994 Feb; 32(2):489-500. PubMed ID: 7512097
[TBL] [Abstract][Full Text] [Related]
20. Borrelia burgdorferi escape mutants that survive in the presence of antiserum to the OspA vaccine are killed when complement is also present.
Solé M; Bantar C; Indest K; Gu Y; Ramamoorthy R; Coughlin R; Philipp MT
Infect Immun; 1998 Jun; 66(6):2540-6. PubMed ID: 9596714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
